Ophthalmic Genetics and Gene Therapy

Gene therapy is an exploratory technique that employs genes to treat or prevent diseases. In near future, this technique may include a doctor replacing the mutated gene with a healthy copy of the gene to the patient in order to cure the abnormalities instead of surgery or drugs. Ophthalmic genetics is a branch of ophthalmology which refers to the field where the genetic background of disease is researched. Liber Congenital Amaris (LCA) is a hereditary genetic disease that causes childhood blindness. Scientists and doctors have treated this disease with the help of gene therapy.

 

  • Genetics of myopia development
  • Gene therapy
  • Usher syndrome
  • Familial exudative vitreal retinopathy
  • Retinoblastoma
  • Leber hereditary optic neuropathy (LHON)
  • Optic atrophy

Related Conference of Ophthalmic Genetics and Gene Therapy

October 02-03, 2023

33rd World Congress on Ophthalmology and Optometry

Paris, France
October 09-10, 2023

4th International Conference on Optometry

Prague, Czech Republic
November 06-07, 2023

7th World Congress on Eye and Vision

Stockholm, Sweden
December 15-16, 2023

18th International Conference on Ophthalmology and Vision Science

Amsterdam, Netherlands
February 22-23, 2024

9th International Conference on Eye and Vision

Zurich, Switzerland
March 14-15, 2024

38th European Ophthalmology Congress

London, UK
March 18-19, 2024

5th World Congress on Ophthalmology and Vision Science

Zurich, Switzerland
April 25-26, 2024

22nd Global Ophthalmologists Annual Meeting

London, UK
May 09-10, 2024

7th International Eye and Vision Congress

Barcelona, Spain

Ophthalmic Genetics and Gene Therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in